reduce post-operative pain in these patients. We aim to assess the efficacy and safety of liposomal bupivacaine infiltration on the BMG harvest site in alleviating pain by evaluating the post-operative pain score, narcotic requirement and associated morbidities.
METHODS: After IRB approval, a single-blinded randomized controlled trial was conducted among adult patients with urethral stricture, that were evaluated suitable for substitution urethroplasty using BMG. Patients were randomized using computer generated allocation scheme to group 1 (liposomal bupivacaine) and group 2 (control). Patient demographic and peri-operative data were collected. Outcome assessed were: post-operative day 1 -2 narcotic use, converted as cumulative morphine equivalents on a 24-hour basis. A validated survey with 10-point visual analogue scale for evaluation of patient reported oral pain score, associated oral morbidities, and oral conditions on post-procedural day 1-3 and 1-month follow-up. Fisherexact test and independent T-test was used to analyze the data with statistical significance set at 0.05 level. (Clinicaltrials.gov registration NCT03720223)
RESULTS: A total of 50 eligible patients were enrolled, 7 were excluded according to predefined exclusion criteria (Group 1: 21, Group 2: 22). No significant baseline characteristics difference was noted between the treatment groups. Compared to group 2, a significantly lesser narcotic requirement was noted among the patients in group 1 on post-op day 1 (IV Morphine equivalent mean difference 8.58; 95%CI 1. 59, 15.56, p[0.017) . No significant between group difference was noted for narcotic requirements on post-op day 2. Likewise, no between group difference was noted for post-procedural oral pain score, and oral morbidities on post-op day 1 to 3, and at 1-month follow-up. For post-procedural oral conditions, a significantly higher number of patients in group 1 have reported oral numbness at postop day 2 (14 (87.5%) vs 8 (44.4%); p[0.013), which was not sustained and equivalent to group 2 at 1-month follow-up.
CONCLUSIONS: Our study showed that Liposomal bupivacaine infiltration to the BMG harvest site is safe and may adequately address the post-procedural oral pain, with noted significantly fewer narcotic requirements at post-op day 1. Although, higher incidence of oral numbness can be reported among these patients on post-op day 2, which was not long-lasting. Future studies may consider to evaluate the cost-effectiveness to determine suitability for routine use.
Source of Funding: None

MP55-09 ENDOSCOPIC TREATMENTS PRIOR TO URETHROPLASTY: TRENDS IN MANAGEMENT OF URETHRAL STRICTURE DISEASE SINCE THE AUA GUIDELINE
Matthew Moynihan*, Burlington, MA; Jeremy Myers, Salt Lake City, UT; Sean Elliott, Minneapolis, MN; Bradley Erickson, Iowa City, IA; Thomas Smith, Houston, TX; Jill Buckley, San Diego, CA; Lee Zhao, New York City, NY; Bryan Voelzke, Seattle, WA; Nejd Alsikafi, Gurnee, IL; Benjamin Breyer, San Francisco, CA; Alex Vanni, Burlington, MA INTRODUCTION AND OBJECTIVES: Endoscopic treatment of urethral stricture disease (USD) continues to be the most common treatment of USD despite its poor success compared to urethroplasty. AUA guidelines regarding the management of male USD were presented in May 2016, advocating consideration of urethroplasty in patients with 1 prior failed endoscopic treatment. The aim of our study is to determine if the number of endoscopic treatments of USD prior to urethroplasty has decreased since the implementation of the AUA guideline.
METHODS: A retrospective review of a prospectively maintained, multi-institutional urethral stricture database of high volume, geographically diverse institutions was performed. We evaluated preurethroplasty endoscopic treatment patterns prior to and after the AUA male stricture guideline.
RESULTS: 2,964 urethroplasties were reviewed in 10 institutions. The overall average number of endoscopic treatments prior to urethroplasty for the entire cohort was 2.15 (SD[ 4.887). There was a decrease in the number of endoscopic treatments prior to urethroplasty in the pre-May 2016 compared to post-May 2016 cohorts both for overall urethroplasties (2.3 vs 1.6, P[0.0012) and anterior urethroplasties specifically (2.6 vs 1.9, P[0.0026).
CONCLUSIONS: This is the first study to demonstrate a decrease in the number of endoscopic treatments of USD prior to urethroplasty since development of the AUA stricture guideline. Further research is needed to determine if there will be a continued trend in the declining use of endoscopic treatment and elucidate the barriers to earlier urethroplasty in patients with USD.
Source of Funding: None
MP55-10 UTILIZATION OF ENDOSCOPIC MANAGEMENT FOR URETHRAL STRICTURES IN AQUA
Andrew J Cohen*, San Francisco, CA; Danil Makarov, New York, NY; Matthew Cooperberg, San Francisco, CA; Raymond Fang, Linthicum, MD; Benjamin N. Breyer, San Francisco, CA INTRODUCTION AND OBJECTIVES: Repeated endoscopic management of urethral strictures has poor long-term success. Recent AUA guidelines on urethral stricture disease encourage early urethroplasty. Contemporary patterns of urethral stricture disease management and the affect of the AUA guidelines on them are poorly understood. We hypothesized that practices with greater numbers of urethral stricture patients would be likely to perform frequent DVIU.
METHODS: We queried the AQUA database using a combination of Current Procedural Terminology (CPT) codes and International Statistical Classification of Diseases (ICD) 9/10 codes to identify patients with urethral stricture and how they were managed. We calculated total patient volume at the practice level as well as frequency of direct vision internal urethrotomy (DVIU) and urethroplasty.
RESULTS: We identified 77,742 unique patients diagnosed with urethral stricture in AQUA since 2014. Caucasians accounted for 75.4% of patients. The patients were cared for by 1343 providers at 171 practices. There was wide variation in utilization of DVIU (Figure 1 ) at both the practice-level and the provider level, where we noted a 20-fold variation. On average, practices performed 0.54 urethroplasties vs. 7.8 DVIU procedures. There was a positive correlation between a greater Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e797
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